CI Cigna
Q3 2025 10-Q
Cigna (CI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 30, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Management Discussion & Analysis
- • No quarterly revenue or YoY change data provided in disclosed text
- • No profitability or margin figures included in provided section
Risk Factors
- • Debt securities portfolio carrying value decreased from $9.4B to $8.4B due to HCSC transaction, unrealized depreciation from rising interest rates
- • Commercial mortgage loan portfolio $1.3B with <25% exposure to office properties amid weak sector fundamentals beginning to stabilize
Quarterly Financial SummaryXBRL
Revenue
$69.7B
▲ +9.5% YoY▲ +3.8% QoQ
Net Income
$1.9B
▲ +152.8% YoY▲ +21.9% QoQ
Operating Margin
3.7%
▼ -35bp YoY▲ +26bp QoQ
Net Margin
2.7%
▲ +152bp YoY▲ +40bp QoQ
ROE
4.5%
Total Assets
$157.9B
EPS (Diluted)
$6.97
▲ +166.0% YoY▲ +22.3% QoQ
Operating Cash Flow
$3.4B
▲ +7330.4% YoY▲ +281.2% QoQ
Source: XBRL data from Cigna Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Cigna Quarterly Reports
Get deeper insights on Cigna
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.